CRYβB2 enhances tumorigenesis through upregulation of nucleolin in triple negative breast cancerYu Yan, Vanessa F. Merino, Zhiqiang Cheng et al.|Oncogene|2021Cited by 13
CRYβB2 is a biomarker for poor prognosis and response to CDK4/6 inhibitors in breast cancerYu Yan, Vanessa F. Merino, Athira Narayan et al.|Research Square|2025Cited by 0